Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 5, 2025

November 5, 2025

Senseonics Holdings, Inc. Reports Third Quarter Financial Results

GlobeNewswire

November 5, 2025

Zevra Reports Third Quarter 2025 Financial Results and Corporate Update

GlobeNewswire

November 5, 2025

RxSight, Inc. Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Pennant Reports Third Quarter 2025 Results

GlobeNewswire

November 5, 2025

Cytek Biosciences Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Mineralys Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire

November 5, 2025

OraSure Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

PacBio Announces Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress

GlobeNewswire

November 5, 2025

Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

Galapagos rapporteert financiële resultaten over de eerste negen maanden van 2025 en geeft bedrijfsupdate

GlobeNewswire

November 5, 2025

Rhythm Pharmaceuticals annonce le remboursement public de l'IMCIVREE® (setmélanotide) au Canada dans cinq provinces et dans le cadre du Programme fédéral des services de santé non assurés

GlobeNewswire

November 5, 2025

HealthEquity Announces Third Quarter Earnings Date

GlobeNewswire

November 5, 2025

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

GlobeNewswire

November 5, 2025

Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Praxis Precision Medicines to Participate in Upcoming Investor Conferences

GlobeNewswire

November 5, 2025

Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire

November 5, 2025

Keros Therapeutics Reports Third Quarter 2025 Financial Results

GlobeNewswire

November 5, 2025

Ascendis Pharma to Report Third Quarter 2025 Financial Results and Provide Business Update on November 12, 2025

GlobeNewswire

November 5, 2025

Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID

GlobeNewswire